蒲公英 - 制药技术的传播者 GMP理论的实践者

搜索
查看: 26595|回复: 89
收起左侧

[其他] 蒲公英独家网络首发:ISPE Baseline Vol 7-MaPP

  [复制链接]
药徒
发表于 2013-6-6 11:21:59 | 显示全部楼层 |阅读模式

欢迎您注册蒲公英

您需要 登录 才可以下载或查看,没有帐号?立即注册

x
     继昨天发布蒲公英独家网络首发重磅资料:ISPE baseline volume4-Water and Steam System 2 之后的又一重磅资料,也是蒲友在找的资料,ISPE Baseline Vol 7-MaPP是ISPE有关风险管理的指南,此版本为电子扫描版,清晰度还可以,经过技术处理可以自由复制,有需要的蒲友可以自行下载,如果需要中文版本的,我们要寄希望于论坛啦@蒲公英


1.jpg 2.jpg 3.jpg
Table of Contents
1 Introduction ..................................................................... .................................... .... ............ 7
1.1 Approach to Identify Highly Hazardous Drugs .................................................................... ......................... 8
1.2 Risk ManagemenUAssessment Model to Address the Controls to Comply with 21 CFR 211.42(c) ............ 8
1.3 How the Approach Fits Into Cleaning Va lidation .... ...... ...... ............................................................ ...... ........ 9
1.4 Background ....... .... ..................... ....................................................... .................................... ............. ..... .. ... 9
1.5 Scope of this Guide .. .... .......... .................................................................................................................... 10
1.6 Current Situation ................................... .......... ... ...................... ....................................... ................ .. ....... .. 1 0
1.7 How to Use this Guide .............................. .................... .. .. ...... ............. .............. .............. .... .......... ............ 11
2 Concepts and Regulatory Philosophy ............................................................................ 13
2.1 Overview of the Risk Management Approach .. ................. ............... .... ................ .. .. .. ........ ......... ... ............ 14
2.2 Acceptable Risk ... ......... .. .. .. ........ ....................................... .. ... ....... ........ ......... ...... ....... .... ..... .. ..... ......... ..... 15
2.3 The GMP and Industrial Hygiene Balance ............ .. .. .. .............. .. .................... ......... .. ............. .. ........ ......... 16
3 Quality System Requirements ......................................................................................... 19
3.1 GxP Quality Policies ....................................................................................................................... .. ......... 19
3.2 GxP Quality Standards ......... ... ..... .. ........... ..... ...... ... ... ........... ... .. .................. .. ... ............................ .. .......... 20
3.3 Gap Analysis ......... ... ....................... ........... ..... ...... .. ....... .... .... ...... ........... ...... ....... .... .. ................................ 20
3.4 Auditing of Quality Systems .... ......................................... ...... .................................................................... 20
3.5 Application to Cross-Contamination ...... ... .... ..... ....... .... ... .. .............. ...... .............................. .. ........ ............. 20
3.6 The Logic Diagram .... ..... .......... ............ .... ........ ... ..... .. ... .... .. ........ .......... ................ .. .............. ... ..... ......... .... 21
4 Risk Assessment ....................... ....................................................................... ................ 31
5 Risk Identification ................................................................. ............................................ 33
5.1 Definition of Hazard ........................... .. .......... .............................................. .. .. ........................... ............... 33
5.2 Hazard Continuum and Prioritization for Risk Assessment.. .. .. .......... ... ...... .. ............................................. 34
5.3 Establishing Health-Based Exposure Limits ............................................ ...................... .. .......... .. .. ............ 35
5.4 Setting Health-Based Safety Thresholds/Acceptance Limits ........ ....... ................. .. .. ..... .. .... ......... .. ...... ..... 42
5.5 Setting Occupational Exposure Limits (OELs) ............... .............. ........ .. ... ............ ... ...... .. ........ ... ... ....... ..... 46
6 Risk Analysis .................. .................. ............. .................................................................... 47
6.1 Holistic Approach to Risk Analysis ................................................. .. ................ ......... ........................... .. .... 48
6.2 Tools ............ .... ..... ........... .......... .......... ............. .... ........... .................. ... ...................................................... 48
6.3 Routes for Cross-Contamination ...................................................................... ... ... .... .......... .... ....... ..... .. .... 50
6.4 Probability of Occurrence ....... ........... ...... ........ .... .................... .................... ........ .......... ........... ....... ... .... .... 55
6.5 Product Exposure Risk in Non-Product Contact Areas ....... .. ..... .. .............................................................. 60
6.6 Detection ........... ............. ... ...................................................... ....................... ..... .... ... ... ................... ... .. ..... 61
7 Risk Evaluation ................................................................................................................. 63
7.1 Cleaning Process Performance Capability ........................................... ....................... .. ............................ 64
7.2 Cleaning Evaluation for New Products .. ......... ........... ...... ........... .... ..... .. ....................... ........................... .. 64
7.3 Residue on Non-Product Contact Surfaces ...... ... ......................... ...... ............................. ... ....................... 64
8 Risk Control. ..................................................................... ................ ............ ..................... 67
8.1 Holi stically Balanced Approach ..... ...... .......... .. ....... ............. .......... ........... ....................... .......... ..... .......... .. 68
9 Risk Reduction .................................................................................................................. 71
9.1 Hierarchy of Risk Reduction ...................................................................................................................... 72
9.2 Risk Reduction: Routes of Exposure ...................................... .... ............................................................... 73
9.3 The Role of Pharmaceutical Research and Development in Risk Reduction .. .. ...... .................................. 76
9.4 Process and Related Technologies ................................................... ................. .. .. ... .. .. ............................. 77
9.5 The Role of Facility Engineering in Risk Reduction .......................... .......... .... ......................................... .. 79
9.6 HVAC .. .............................................................................. ....... ...... .... .......................................... ... ... ........ 84
9.7 Containment Related Technologies .. ........ ..... ...... ............... ..... ................. .................. ..... .. ........ ..... ........... 85
9.8 Personal Protective Equipment (PPE) and Gowning ............................... .. .. ...... .. ......... ............ .... ............. 86
10 Risk Acceptance ............................................................................................................... 87
11 Risk Management Tools ................................................................................................... 89
11 .1 Risk Ranking or Risk Matrix ....................................................................................................................... 90
11 .2 Failure Mode and Effects Analysis (FMEA) ............................................................................................... 91
12 Risk Review ....................................................................................................................... 95
13 Risk Communication ............................ ............................................................................ 97
13.1 Summary Document Template ....................................................................... ........ .................................... 98
14 Appendix 1- Risk-MaPP Application Examples .......................................................... 101
14.1 lntroduction .. ....................... ........... ........... ..... ....... .............. .......... ................ .. ......... ................................ 101
14.2 Scenario 1 (Obviously Acceptable) .... .............................. ......... ... ........ ..................................... ............... 102
14.3 Scenario 2 (Obviously Unacceptable) ............................................... ............... .. ... .. .......................... ....... 105
14.4 Scenario 3 (Apparently Acceptable (but was not)) .............................................................. ............ .. .... ... 107
14.5 Scenario 4 (Apparently Unacceptable (but was)) ..................... ............... .. ....................................... .. ..... 117
14.6 Logic Diagram ............................................................................................. ............................. .. .............. 128
15 Appendix 2- Bibliography ............................................................................................. 129
15.1 References ............................................................................................................................................... 129
15.2 Reading List ......................................................................... .. .................................................................. 133
16 Appendix 3 - Glossary ................................................................................................... 137
16.1 Abbreviations and Acronyms .. ................................................................................................................. 137
16.2 Definitions .. ................... .... ............................................................. .... ......... ... .. ............. ... ........................ 141

附件下载:
ISPE Baseline Vol 7-MaPP.pdf (35.14 MB, 下载次数: 7185, 售价: 8 金币)

评分

参与人数 3金币 +33 +2 收起 理由
GmpForEver + 8 疯了,疯了!
毒手药王 + 5 很给力!
蒲公英 + 20 + 2 贡献,奖励

查看全部评分

回复

使用道具 举报

药师
发表于 2016-9-12 14:26:45 | 显示全部楼层
ISPE Baseline Volume 7
Risk-Based Manufacture of Pharmaceutical Products
First Edition / September 2010
来自:Pharmout GMP Library(已关闭)


补充内容 (2016-10-24 13:25):
与楼主的不是同一版本

BG V7_Risk-MaPP 2010.part1.rar

7.44 MB, 下载次数: 171

售价: 1 金币  [记录]

BG V7_Risk-MaPP 2010.part2.rar

6.38 MB, 下载次数: 171

售价: 1 金币  [记录]

小一点

回复

使用道具 举报

药徒
发表于 2013-6-6 11:22:56 | 显示全部楼层
沙发沙发啦~~!!!第一次哦!
回复

使用道具 举报

药徒
 楼主| 发表于 2013-6-6 11:24:27 | 显示全部楼层
比我还快{:soso_e127:}
回复

使用道具 举报

大师
发表于 2013-6-6 11:26:21 | 显示全部楼层
蒲公英在此,请与我联系,将中文版发送到邮箱chinapat@foxmail.com     我们会与您配合完成,感谢支持

点评

额 本人也在祈求中文版本,把英文版本的传上来共享,也是希望借助论坛的力量,人多力量大嘛  详情 回复 发表于 2013-6-6 11:29
回复

使用道具 举报

药徒
 楼主| 发表于 2013-6-6 11:29:31 | 显示全部楼层
蒲公英 发表于 2013-6-6 11:26
蒲公英在此,请与我联系,将中文版发送到邮箱     我们会与您配合完成,感谢支持

额 本人也在祈求中文版本,把英文版本的传上来共享,也是希望借助论坛的力量,人多力量大嘛
回复

使用道具 举报

药徒
发表于 2013-6-6 11:41:16 | 显示全部楼层
库拉赛尅伊姬谷 发表于 2013-6-6 11:24
比我还快

这两天论坛真是重磅不断啊~!!
还在期待哦~~ISPE还有很多书籍!比如固体制剂和API,还有Process gas~~
回复

使用道具 举报

药徒
发表于 2013-6-6 12:20:34 | 显示全部楼层
真好 要是有中文版的就好了
回复

使用道具 举报

宗师
发表于 2013-6-6 12:32:56 | 显示全部楼层
要是有中文版的就好了,支持首发
回复

使用道具 举报

药生
发表于 2013-6-6 13:07:23 | 显示全部楼层
好东东,收藏了!!
回复

使用道具 举报

药徒
发表于 2013-6-6 15:30:39 | 显示全部楼层
楼主辛苦,下载收藏
回复

使用道具 举报

药士
发表于 2013-6-6 16:08:58 | 显示全部楼层
不是人,是神啊。。。。。。。。。。
回复

使用道具 举报

药徒
发表于 2013-6-6 16:28:51 | 显示全部楼层
回复

使用道具 举报

药徒
发表于 2013-6-6 16:32:28 | 显示全部楼层
蒲公英越来越壮大了,这两天真是惊喜不断。
回复

使用道具 举报

发表于 2013-6-10 08:56:16 | 显示全部楼层
太好了,非常感谢楼主!!非常感谢!
回复

使用道具 举报

发表于 2013-6-10 08:59:13 | 显示全部楼层
我就喜欢原版的书,没有翻译!看起来爽!
回复

使用道具 举报

发表于 2013-6-10 09:05:43 | 显示全部楼层
原版的 !好呀!
回复

使用道具 举报

发表于 2013-6-10 09:11:30 | 显示全部楼层
下来学习,谢谢
回复

使用道具 举报

药徒
发表于 2013-6-10 10:38:30 | 显示全部楼层
很不错的资料,感谢分享~
回复

使用道具 举报

药徒
发表于 2013-6-13 20:31:38 | 显示全部楼层
感谢分享  很好的资料
回复

使用道具 举报

发表于 2013-6-14 11:06:20 | 显示全部楼层
这样的书真是值得收藏 多谢楼主分享
回复

使用道具 举报

您需要登录后才可以回帖 登录 | 立即注册

本版积分规则

×发帖声明
1、本站为技术交流论坛,发帖的内容具有互动属性。您在本站发布的内容:
①在无人回复的情况下,可以通过自助删帖功能随时删除(自助删帖功能关闭期间,可以联系管理员微信:8542508 处理。)
②在有人回复和讨论的情况下,主题帖和回复内容已构成一个不可分割的整体,您将不能直接删除该帖。
2、禁止发布任何涉政、涉黄赌毒及其他违反国家相关法律、法规、及本站版规的内容,详情请参阅《蒲公英论坛总版规》。
3、您在本站发表、转载的任何作品仅代表您个人观点,不代表本站观点。不要盗用有版权要求的作品,转贴请注明来源,否则文责自负。
4、请认真阅读上述条款,您发帖即代表接受上述条款。

QQ|手机版|蒲公英|ouryao|蒲公英 ( 京ICP备14042168号-1 )  增值电信业务经营许可证编号:京B2-20243455  互联网药品信息服务资格证书编号:(京)-非经营性-2024-0033

GMT+8, 2024-11-28 07:29

Powered by Discuz! X3.4运维单位:苏州豚鼠科技有限公司

Copyright © 2001-2020, Tencent Cloud.

声明:蒲公英网站所涉及的原创文章、文字内容、视频图片及首发资料,版权归作者及蒲公英网站所有,转载要在显著位置标明来源“蒲公英”;禁止任何形式的商业用途。违反上述声明的,本站及作者将追究法律责任。
快速回复 返回顶部 返回列表